FDA cleared the AngioWaveNet from Angiowave Imaging, Inc. on Sep 10, 2025 under K244002, a traditional 510(k). The device falls under product code QIH, Automated Radiological Image Processing Software, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Dec 26, 2024. The decision came 258 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Angiowave Imaging, Inc. in the last 12 months of the tracker.